Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Latest filing published 03 Sept 2026 for Veracyte, INC., €69k. Read the official filing
Filing timeline
BuySaleMuna Bhanji
Insider track record
Disclosed buys
0
Disclosed sells
14
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Muna Bhanji: trading record in brief
Muna Bhanji is a declared insider at 4 companies; the most frequent names are Cytokinetics Inc, Intellia Therapeutics, Inc. and Veracyte, Inc. Between 12 May 2021 and 1 September 2026, the trades on record add up to 38 filings.
On the market, this insider has only sold: 14 sales, €740k in total. Outside the open market, there are 24 share grants. 2026 to date brings no purchases and 1 sale.
On 3 September 2026 came the latest disclosure, an open-market sale for €69k in Veracyte, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Muna Bhanji
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations38 total
1,864 shares@ US$42.970.0023% mcap15.2% of flowCommon StockSEC:0001846905-26-000006:0
26,455 sharesCommon StockSEC:0001846905-26-000004:0
5,272 sharesCommon StockSEC:0001846905-26-000002:0
9,200 sharesCommon StockSEC:0001193125-26-266230:0
2,851 shares0Common StockSEC:0001061983-26-000062:0
41,551 shares0Common StockSEC:0001628280-25-032725:0
9,321 shares0Common StockSEC:0001384101-25-000094:0
4,589 shares@ US$26.665227.4% of flowCommon StockSEC:0001384101-25-000079:0
8,000 shares0Common StockSEC:0000950170-25-086243:0
1,454 shares@ US$29.7315.4% of flowCommon StockSEC:0001127602-25-014556:0
7,333 shares0Common StockSEC:0001127602-25-014365:0
265 shares@ US$8.502.2% of flowCommon StockSEC:0000950170-25-061881:0
265 shares@ US$9.972.9% of flowCommon StockSEC:0000950170-25-011757:0
11,473 shares0Common StockSEC:0001384101-24-000102:0
7,737 shares0Common StockSEC:0000950170-24-073685:0
3,870 shares@ US$20.318826.1% of flowCommon StockSEC:0001384101-24-000086:0
2,000 shares@ US$52.0738.7% of flowCommon StockSEC:0001127602-24-018246:0
1,539 shares@ US$21.0010.6% of flowCommon StockSEC:0001384101-24-000069:0
5,600 shares0Common StockSEC:0001127602-24-015725:0
265 shares@ US$23.906.8% of flowCommon StockSEC:0001209191-23-054163:0
265 shares@ US$42.3311.6% of flowCommon StockSEC:0001209191-23-044257:0
1,867 shares@ US$39.3076.5% of flowCommon StockSEC:0001209191-23-041951:0
2,000 shares@ US$34.117325.1% of flowCommon StockSEC:0001127602-23-020455:0
5,793 shares@ US$26.424450.0% of flowCommon StockSEC:0001384101-23-000128:0
4,425 shares0Common StockSEC:0001209191-23-037860:0
25 of 38 declarations
